25th November 2022 | Pharma Updates

Latest pharmaceutical industry news and updates

*Refresh the page if the below document does not appear.

Eli Lilly markets Ramiven drug in India for high-risk early breast Cancer patients

The drugmaker Eli Lilly announced that its drug ‘Ramiven’ which is already approved for the treatment of certain types of HR+ HER2- advanced or metastatic breast cancer has added indication following approval from the (DCGI) Drug Controller General of India.

USFDA declares Cipla's Goa facility as "Official Action Indicated"

The Indian drug major Cipla announced on Thursday that USFDA designated its Goa manufacturing unit as OAI (Official Action Indicated) which will impact the product approvals to be marketed in the US.

Despite volatility, agile investment managers have added these pharma stocks recently

Pharma stocks experienced a return in 2020 following the COVID-19 outbreak but the performance has been declining recently. Sun Pharma, Cipla, and Syngene are a few in the top 10 list of pharma and healthcare stocks that have been added by active fund managers lately.

Maharashtra FDA issues nationwide recall of Emcure Pharma's Orofer FCM

The Maharashtra Government issued an order to recall Emcure Pharma’s Orofer FCM injection indicated for the treatment of Iron Deficiency Anemia after the death of a patient due to suspected ADR (Adverse Drug Reaction) following the administration of the drug.

Orchid Pharma's antibiotic product indicated for UTIs coming to India: MD

Orchid Pharma was acquired by Dhanuka Laboratories under insolvency resolution back in March 2020. According to a senior executive, the drugmaker is observing a turn-around in revenue and has increased its profits with the commercialization of a molecule developed inhouse.

Delhi HC fines ₹10 Lakh to Sun Pharma over concealment of facts

On Monday, the Delhi High Court issued a fine of ₹10 lakh for the concealment of facts on Sun Pharma about a trademark infringement case, mentioning that not only does such a practice has to be deprecated but it also has to be penalized.

Technology's crucial role in the advancement of Pharma Industry

At the second edition of the Economic Times Healthcare Leaders Summit 2022 leaders of the pharmaceutical industry discussed about various aspects of technological advancements and its positive impact in pharma and healthcare.

PharmaState.academy offers easy access to training & up-skilling programs created by experts from Pharma Industry.
Start chat
Need Help?
PharmaState Academy
Hello, how can we help you?